PRISCILLA COLLIER: Open Payments
NPI 1669205308 · HARRISON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 33 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $220 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $100 |
| Exelixis Inc. | 5 | $91 |
| Incyte Corporation | 4 | $71 |
| TAIHO ONCOLOGY, INC. | 2 | $59 |
| Regeneron Healthcare Solutions, Inc. | 3 | $50 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| BeOne Medicines USA, Inc. | 3 | $47 |
| GENZYME CORPORATION | 1 | $27 |
| Iovance Biotherapeutics, Inc. | 1 | $21 |
| ARRAY BIOPHARMA INC | 1 | $21 |
Products named: CABOMETYX, LONSURF, IBRANCE, JAKAFI, LIBTAYO, BRUKINSA, KEYTRUDA, HYMPAVZI.
Industry payments across AR — which companies pay providers there.
